The minimum requirements for soya-based infant formulae and follow-up milks (Opinion delivered on 9 December 1988). Reports of the Scientific Committee for Food. Twenty-third series. EUR 12536 EN by unknown
Commission of the European Communities 
food—science and 
techniques 
Reports of the Scientific Committee 
for Food 
(Twenty-third series) Commission of the European Communities 
ood—science and 
techniques 
Reports of the Scientific Committee 
for Food 
(Twenty-third series) 
The minimum requirements for soya-based 
infant formulae and follow-up milks 
(Opinion delivered on 9 December 1988) 
Directorate-General 
Internal Market and Industrial Affairs 
1989 EUR 12536 EN Published by the 
COMMISSION OF THE EUROPEAN COMMUNITIES 
Directorate-General 
Telecommunications, Information Industries and Innovation 
L-2920 Luxembourg 
LEGAL NOTICE 
Neither the Commission of the European Communities nor any person acting 
on behalf of the Commission is responsible for the use which might be made of 
the following information 
This publication is also available in the following languages: 
ES ISBN 92-826-1075-6 
DA ISBN 92-826-1076-4 
DE ISBN 92-826-1077-2 
GR ISBN 92-826-1078-0 
FR ISBN 92-826-1080-2 
IT ISBN 92-826-1081-0 
NL ISBN 92-826-1082-9 
PT ISBN 92-826-1083-7 
Cataloguing data can be found at the end of this publication 
Luxembourg: Office for Official Publications of the European Communities, 1990 
ISBN 92-826-1079-9 Catalogue number: CD-NA-12536-EN-C 
© ECSC-EEC-EAEC, Brussels · Luxembourg, 1990 
Printed in Belgium Abstract 
In the present report the Scientific Committee for Food expresses its opinion 
on the essential requirements of infant formulae and follow-up milks based on 
soya protein isolates. Reasons for using these products and their basic 
composition in proteins, lipids, glucides, minerals and vitamins are reviewed. 
The Committee's opinion is that, in order to meet the nutritional requirements 
of infants and small children, soya-based products should be required to be 
supplemented with certain substances. 
The recommendations of the Scientific Committee for Food on the essential 
requirements of infant formulae and follow-up milks based on cows' milk 
proteins was published inl983 {Reports of the Scientific Committee for Food, 
Fourteenth series, EUR 8752, p. 9). 
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VI First Report of the Scientific Committee for Food 
on the Minimum Requirements for 
Soya-based Infant Formulae and Follow-up Milks 
(Opinion delivered on December 9, 1988) 
Terms of Reference: 
To advise on the minimum requirements for soya
Lbased products intended for the feeding of 
infants and young children. 
Introduction 
Area of application 
1. In 1983 the Committee adopted an opinion on the minimum requirements for infant formulae and 
follow-up milks based on cows' milk proteins. The Committee was aware at the time that on the 
Community market there were products based on proteins other than cows' milk proteins, but in 
view of the deadlines to which the Committee was working, it preferred to postpone specific 
recommendations on these products*. 
The present opinion addresses this issue with regard to soya-based products. The Committee felt 
that there was no need for the time being to put forward recommendations on the criteria to be 
applied to products incorporating vegetable proteins other than soya proteins, since that type of 
product is not marketed in the Community at present. Quite apart from the normal procedures for 
revising directives, this position will have to be reviewed if new products appear on the market 
incorporating vegetable proteins other than soya proteins. 
In all events, the present opinion is only concerned with products intended to replace breast milk 
where necessary, i.e. infant formulae and those products intended to form the 'milk' element in 
food for children over four months old as part of an increasingly diversified diet. Soya-based 
products which are not presented as 'suitable for infants and young children' are excluded from the 
area of application. Also excluded are products for infants of low birth weight and for infants and 
children with nutritional or metabolic disorders. 
Definitions 
2 . In accordance with the Committee's 1983 report the following definitions have been used: 
'Infants': children under the age of twelve months. 
'Young children': children from the age of one to three years old. 
: Reports of the Scientific Committee for Food (Fourteenth series), 1983, p. 9. 
- 1 'Infant formulae': products intended to replace breast milk where necessary and to satisfy fully 
the normal nutritional needs of infants during the first four to six months of life. 
'Follow-up milks': products intended to form the basic milk element in food for children over 
four months old as part of an increasingly diversified diet. 
Data sources 
3 . In drawing up this draft report the Committee had the benefit of useful information provided by 
IDA CE (Association of Dietetic Food Industries of the EEC). 
Products available in the Community 
4 . Soya-based infant formulae have been available in the Community for many years. Rightly or 
wrongly, they are used chiefly as breast milk substitutes in cases where there is a suspicion or 
evidence of intolerance to cows' milk protein (secondary use) and in new-bom babies and infants 
where there is a risk of allergy (primary use). They are also used, albeit less and less commonly 
owing to the development of formulae based on hydrolysed protein, for patients recovering from 
some forms of gastro-enteritis. Because these formulae contain no lactose they are also suitable as 
substitutes for breast milk and for milk-based formulae for certain cases of lactose intolerance and 
for children suffering from galactosaemia. Lastly, these formulae are sometimes chosen by 
consumers who, for various reasons, do not wish to give their children products based on animal 
protein L
2. 
5 . Soya-based infant formulae and follow-up milks are put up in the form of powder, ready-to-feed 
liquids or concentrated liquids. The methods used to prepare them are similar to those used to 
manufacture infant products based on cows' milk. 
Basic Composition 
6 . Generally speaking, vegetable proteins have a lower nutritional value than animal proteins. This is 
partly due to the fact that they contain a limiting amount of one or more essential amino-acids
 3. 
Moreover, vegetable proteins are often difficult to digest and the bioavailability of the limiting 
amino-acid(s) can be considerably lower
 4. That is why, according to the Codex Committee on 
Vegetable Proteins (CCVP), it is the chemical index of a protein, if necessary adjusted to take 
account of its digestibility and/or the bioavailability of the amino-acids, which nowadays is 
regarded as the most appropriate method of evaluating the nutritional quality of vegetable 
proteins
 5. The corrected relative net protein ratio (CRNPR), which is superior to the conventional 
protein efficiency ratio (PER), could also be chosen as a method of evaluation, particularly where 
the sulphur amino-acids are limiting, as in the case of soya
 6. 
7 . However, of the vegetable proteins, soya is one of those with the highest nutritional value. Its 
amino-acid rating is actually 96% of that of casein; even when corrected to allow for the 
digestibility of the proteins, soya's rating is still 89% and remains above 80% when the 
bioavailability of each amino-acid is taken into account
 5. Secondly, the CRNPR of soya protein 
isolates is never more than 10% lower than those of beefmeat or casein, and soya concentrates 
score even higher (97%), doubtless on account of the slightly higher sulphur amino-acid content in 
this type of product
 6. 
8. For adults it is well established that soya protein, correctly treated, is an excellent source of 
protein, approaching or even on a par with foods of animal origin. It is also well established that 
soya proteins alone are perfectly capable of supplying an adult's requirements of nitrogen and 
essential amino-acids as long as the recommended intake of proteins with high nutritional value is 
covered. Where the protein intake is inadequate, the body's use of soya protein is improved by the 
addition of L-methionine, but adverse effects on protein use have been observed with methionine 
- 2-Supplements at levels not appreciably higher than the recommended intake. Under normal 
conditions for soya protein use in adults it is therefore generally accepted that a methionine 
supplement is unnecessary and probably even undesirable
 3. In fact this has been confirmed by all 
of the recent short-term and long-term studies with soya protein isolates or soya concentrates; they 
have shown that the nutritional value of these proteins is comparable to that of eggs, milk and 
meat, and that their methionine content is not limiting as regards protein maintenance in adults
7"
12. 
9. For children of pre-school age, soya protein isolates, provided they have undergone proper 
technological processing, have proved to be an excellent source of protein. Their effect on nitrogen 
retention, in particular, bears comparison with that of milk protein; depending on the method of 
comparison chosen, the nitrogen balance ranges from 86% to 107% of that obtained with cows' 
milk proteins. With an intake of 160 mg N (equivalent to 1 g of protein) per kg of body weight per 
day, all of the children studied retained sufficient quantities of nitrogen to allow growth and to 
cover basal losses. Moreover, this level of intake coincides with the level at which plasma protein 
concentrations are maintained
 13. 
10. The nitrogen balance results obtained on infants suggest that the same holds true during the first 
few months of life, provided methionine-supplemented formulae are used. In the case of six infants 
aged between 3*/2 and 4 months, at protein intakes accounting for not more than 6.5% of the total 
energy intake, no difference in nitrogen retention was observed between methionine-supplemented 
soya protein isolates on the one hand and formulae based on cows' milk or breast milk on the 
other. At high protein intakes accounting for 8 to 11% and 12 to 16% of energy, there is a high 
degree of similarity in the nitrogen balance of infants aged between 8 and 120 days, whether they 
are fed with formulae based on cows' milk or on isolated soya proteins with a methionine 
supplement. In infants more than 4 months old and in young children, soya protein is even claimed 
to give better nitrogen retention than milk protein-based products
 14. Moreover, a whole series of 
studies have shown that formulae based on methionine-supplemented soya protein isolates allow 
infant growth comparable with that of babies fed with milk based formulae
 14·
15. 
11. Contrary to what is observed in adults or in pre-school age children, a methionine supplement 
appears to be necessary for infants, even where the protein intake is not marginal. Wim protein 
intakes of the order of 2.25 g/kg body weight, accounting for about 9% of energy, significant 
differences were observed in terms of the speed of growth, the concentration of albumin in the 
plasma and the excretion of urea in the urine between a group of infants receiving a non-methionine 
supplemented formula (26 mg of methionine/100 kcal) and those fed on a supplemented formula 
(32 mg/100 kcal)
16. Recent studies in Cebus monkeys have in fact confirmed the beneficial effects 
on growth and nitrogen retention of supplementing the diet with methionine during the first few 
weeks of life
 17. 
The Committee therefore considers that special precautions should be taken to 
ensure optimum methionine intake from soya-based infant formulae. It therefore 
decided that for soya-based infant formulae it would not be sufficient to group 
together the sulphur amino-acids methionine and cystine (as is done for milk-
based formulae) for the purpose of calculating the chemical index. Provided that 
the other requirements applicable to the proteins listed in Annex 1 of the 
Committee's 1983 report are satisfied, then - energy values being equal - soya 
protein-based infant formulae should provide an available quantity of methionine 
not lower than that contained in breast milk. 
12. The Committee's attention was also drawn to the possible effects of vegetable protein on the level 
of cholesterol in the blood (cholesterolaemia). Most of the available data come from studies on 
laboratory animals. Generally speaking they show that hypercholesterolaemia and atherosclerotic 
lesions comparable with those caused by a high-cholesterol diet could be induced in rabbits and 
rats by a casein-based diet, and that these effects could be reversed when vegetable protein, 
especially soya, was substituted for animal protein
 18. On chickens and turkeys, soya had no 
effect, but a lessening of cholesterolaemia, mainly affecting LDLs, was observed in pigs and rhesus monkeys, which suggests that the role of dietary protein in this area is not confined to 
laboratory animals
 19. Nevertheless, the results in humans are not conclusive. 
Studies carried out on healthy volunteers revealed little or no effect as a result of substituting soya 
protein for casein
 20. Nor was any difference observed in the rate of total cholesterolaemia, LDLs, 
HDLs or apolipoprotein Β in several groups of subjects suffering from varying degrees of 
hypercholesterolaemia
 2L
22. However, in other studies the replacement of animal proteins by soya 
protein did lead to a certain reduction in cholesterolaemia, particularly in subjects suffering from 
familial hypercholesterolaemia, in whom soya proteins would appear to cause a very considerable 
increase in LDL receptor activity
 23. Yet there is virtually no information on the effects of soya 
protein on cholesterolaemia in infants and nothing to indicate that cholesterolaemia in breast-fed 
infants is the ideal bench-mark. The Committee therefore proposes that until 
indisputable facts are available in this respect, no claims as to the possible 
favourable effects of these products on the regulation of cholesterolaemia should 
be accepted. 
13. Soya flour is never used in an untreated form in the preparation of infant formulae in the 
Community. In the few products where protein isolates are not used, the soya flour is always de­
fatted, generally leaving a fat content under 1 %
 2. The fatty phase of all products of this type 
currently marketed in the Community is therefore made up of mixtures of vegetable oils - such as 
safflower, coconut, com, palm, soya, and sunflower oils - to which butter fat or destearinized 
beef fat (oleo oil) may be added. The fat content of these products is generally in the range between 
4 and 5.5 g/100 kcal; the linoleic acid content (18:2, n-6), save for exceptions, ranges from 15 to 
30% of the fatty acids content, but it can be as high as twice the maximum values permitted for 
milk-based products (max. = 1200 mg/100 kcal). There is no real justification for these practices. 
The Committee therefore agreed to recommend that soya-protein-based formulae 
must comply with the specifications laid down for lipids and Iinoleate in milk-
based products. 
14. In the 1983 report, for a number of reasons, the Committee felt that the lactose content of milk-
based infant formulae should be not less than half of their minimum carbohydrate content. A 
minimum lactose content of 3.5 g/100 kcal was set for milk-based products. Whilst lactose is an 
essential constituent of milk, this is not the 'case for soya and no soya-based product contains 
lactose. That is precisely why these formulae are recommended when lactose has to be eliminated 
from the diet, for example in cases of primary lactase deficiency or for the treatment of 
galactosaemia, or where a temporary exclusion of lactose is considered desirable - as in the case of 
secondary lactose intolerance induced by an enteral infection or any other condition leading to 
intestinal lesions
 24. Consequently, the Committee took the view that the provisions 
governing the minimum lactose content could not apply to soya-based products 
and that statements that they contained no lactose, together with any relevant 
medical indications, should appear on the labelling. 
15. Apart from lactose, for which special provisions should be envisaged, there is no apparent reason 
for departing from the provisions relating to milk-based products in the Glucides sections of 
Annexes 1 and 2 to the Committee's 1983 opinion. Consequently, the Committee took the 
view that these provisions should also be applied to soya-based products, but that 
hydrolysed starch products - such as corn syrup solids - should be added to the 
list of sugars authorized for infant formulae. 
16. Owing to the absence of oc-galactosidase in the human upper intestine, galactosido-oligosaccharides 
such as raffinose, stachyose and verbascose are not digested. De-fatted soya flour contains only 
traces of verbascose, but raffinose and stachyose each represent about 4 to 5% of the content, 
accounting for nearly two-thirds of the soluble soya carbohydrates. Their fermentation in the colon 
by intestinal micro-organisms was responsible for the flatulence and abundant loose and 
malodorous stools observed so frequently with the first generation of soya-flour-based infant 
formulae. By and large these problems are not encountered with soya protein isolates whose carbohydrate content is lower than 0.5%. Stachyose and raffinose are also eliminated, like all 
soluble carbohydrates, during the manufacture of soya protein concentrates (by definition the 
minimum protein content is not less than 65% of the dry extract). But all of the insoluble 
carbohydrates, chiefly cellulose and hemicellulose, remain in the concentrate with the possible risk 
of fermentation
 2·
 25. The Committee therefore took the view that de-fatted soya flour 
and soya concentrates were not suitable raw materials for the manufacture of 
soya-based infant formulae and follow-up milks. Thus only protein isolates from 
soya should be used for manufacturing these products. 
17. Soya is well-known for its relatively high phytate content (between 1 and 2%). Phytates are only 
partially eliminated during the preparation of protein isolates. In adults, when meat proteins are 
replaced by soya proteins, the bioavailability of non-heme iron is lowered chiefly because phytates 
form highly insoluble complex compounds with ferric salts
 26-
28. The inhibiting effect of soya on 
the bioavailability of iron is shown up again in adults by a comparison of the absorption of iron 
contained in milk-based infant formulae with the absorption of iron in formulae based on soya 
protein isolates. At ferrous sulphate intakes of 6 mg per 100 g of powder (1.2 mg/100 kcal), the 
geometric mean of iron absorption is reduced by more than half in the case of soya. Calculations 
suggest that, in these formulae, iron concentration should not be less than 2.4 mg/100 kcal in the 
presence of ascorbic acid when the ascorbic acid/iron ratio is of 4:1
 29. The very weak absorption 
(under 2%) of ferrous sulphate which has been added to a soya protein isolate-based formula in a 
concentration of 12 mg per litre of ready-to-feed product has recently been confirmed in adults. 
However, it has been shown that there is no difference in iron status between infants who were fed 
this product up to the age of 9 months and children receiving a milk-based formula with the same 
iron content (2.2 mg/100 kcal), a level known for its effectiveness in preventing anaemia due to 
iron deficiency
 30. Despite the limited bioavailability of iron when it is measured in adults, soya-
based infant formulae therefore seem to be just as effective as milk-based preparations in 
preventing iron deficiency, provided the iron content is sufficiently high. Under these 
circumstances the Committee proposed that, in contrast to the provisions for milk-
based formulae, soya-protein-based infant formulae must be required to be 
enriched with iron, at concentrations of not less than 1 mg and not more than 2 
mg per 100 kcal. 
18. Phytates have an even more pronounced effect on the bioavailability of zinc than on that of iron. 
Zinc chelation is aggravated by an excess of calcium. Where there are no phytates the excess 
calcium has no effect on the absorption of zinc. This suggests that calcium, zinc and phytates forni 
highly insoluble complex compounds which reduce zinc absorption to a greater extent than 
phytates on their own
 26. In addition, inorganic iron seriously inhibits the absorption of zinc where 
the iron-to-zinc ratio is greater than 2:1 31. This inhibiting effect of iron, however, was not found 
in the case of soya-based products, perhaps because the iron can form a complex compound with 
the phytates and thus facilitate zinc absorption
 32. 
At the concentrations normally used in infant formulae (3-4 mg/1), absorption of zinc measured in 
adults
 3
2 or based on the model of the suckling rat
3
3 is much lower (nearly 50%) with soya-based 
than with milk-based formulae. Secondly, the increase in zinc concentrations in milk-based 
formulae gives an absorption comparable to that of suckling infants, but this objective cannot be 
achieved to the same extent with soya-based formulae
 32. This suggests that a reduction in phytate 
content to the sort of level at which the phytate-to-zinc ratio would be less than 10:1 is likely to be 
more effective than an additional increase in the zinc content of soya-protein-based formulae
 32. 
However, reducing the phytate content poses a number of as yet unresolved technological 
problems. The Committee therefore concluded that soya-based products should be 
required to have a higher minimum zinc content than infant formulae and follow-
up milks based on cows' milk protein (0.3 and 0.5 mg/100 kcal respectively). 
This minimum zinc content should not be less than 0.75 mg/100 kcal. 
19. The effects of soya-based products on the bioavailability of minerals other than iron and zinc are 
more doubtful. Poor bone mineralization has been observed in infants receiving this type of 
-5 product compared with those fed on milk-based products
 15·
 34. In one of these studies, these 
differences, occurring at the age of 3 months, had disappeared at the age of 6 months
 34. In the 
other, where the differences continued until the age of 1 year, the reduction in bone density was no 
greater than in breast-fed children receiving vitamin D supplements who were studied earlier
15. A 
fall in the absorption or retention of calcium and/or phosphorus might explain these differences, the 
long-term significance of which has not yet been determined
 35. 
20. There is very little information about the bioavailability of other minerals and trace elements 
contained in soya-based products. Experiments in chickens with EDTA indicate that soya can bind 
copper and manganese, but adverse effects are only observed if the intake of one or other of these 
elements is limiting
 26. It has also been demonstrated in growing rats that copper was absorbed as 
efficiently from soya protein isolates as from a copper carbonate solution
 36. However, although 
the bioavailability of manganese is reduced in the case of soya-based products, concentrations of 
manganese in these formulae are in most cases so much higher than those found in breast milk that 
there is very little likelihood of a deficiency
 37. Lastly, although there are a number of findings to 
indicate that phytates might reduce the bioavailability of magnesium, it would appear that soya 
proteins have no significant effect on its bioavailability
 26. The Committee therefore took the 
view that there was no need, in the case of minerals other than iron and zinc, to 
alter the specifications for milk-based infant formulae laid down in Annex 1 of the 
Committee's 1983 opinion. The Committee was not presented with any findings to 
warrant amending the specifications on vitamins. 
21. Particular attention must be paid to L-camitine, which is indispensable to the transport of long-
chained fatty acids within the mitochondria and plays a key role in the oxidation of fatty acids, 
thermogenesis of brown adipose tissue and initiation of ce togenesis. It is synthesized in the body 
from lysine and methionine (which is a methyl group donor). The ability of a newborn infant to 
synthesize carnitine, however, is extremely limited, even though this product is critical to it during 
its first few hours of life. The newborn infant therefore has to rely chiefly on its prenatal reserves 
from the mother and exogenous intakes
 38·
39. Its reserves, estimated at around 2 mmoles at birth, 
are certainly sufficient to cover its needs during the first few weeks; if no exogenous supplies are 
forthcoming, it has been calculated that reserves fall by around 25% in 15 days and that they are 
liable to be completely exhausted after two and a half months 40,41. The concentration of carnitine 
in colostrum is close to 10 umoles, stabilizing at an average of between 4 and 5 umoles/100 ml in 
the milk of a mature female from the first month onwards
 42. Cows' milk is also a good source of 
carnitine and milk-based preparations have naturally-occurring concentrations of carnitine which 
are as high as those in breast milk. 
Soya, on the other hand, like all plants, contains practically none and the content of soya-based 
formulae, unless they are supplemented with carnitine, is close to zero 42,43. instances of 
hypoglycaemia, vomiting, hypothermia, accompanied by hepatomegalia and steatosis have been 
reported in an infant fed with one of these soya-based formulae 44 but it has still to be conclusively 
demonstrated that reduced carnitine intake during the first few weeks of life has harmful effects
 38. 
In any case, the Committee took the view that soya-based products should be 
systematically enriched with L-carnitine. Given the carnitine content of breast 
milk and its higher bioavailability in human milk than in infant formulae, the L-
carnitine content of soya-based formulae must not be less than 7.5 μπιοΙε/ΙΟΟ 
kcal. For the purposes of implementing this measure, L-carnitine should be added 
to the list of nutritional substances (the section dealing with amino-acids and 
other nitrogenous compounds) in Annex 4 of the Committee's previous 1983 
opinion. 
22. On the question of technological additives, particular attention should be paid to thickeners, a 
number of which are essential to the stability of the milk-based (ready-to-use) liquids and soya-
based formulae. Several of these are on the list of additives in the Codex standard for infant 
formulae (CODEX STAN 72-1981). The Committee therefore recommended the holding of consultations with the IDACE to review the lists, in accordance with the 
principles established in § 43 of the Committee's previous 1983 opinion. 
2 3. Vegetables and vegetable products eaten as foods contain a number of minor chemical compounds 
which can have undesirable effects. Soya is no exception to this rule, containing in particular 
trypsin inhibitors, phytohemagglutinins (lectins), goitrogenic substances, oestrogens and 
galactosido-oligosaccharides (see § 16 above)
 25· 45. The Committee therefore pointed out 
that every effort should be made to reduce the concentrations of these substances 
to the lowest level compatible with good manufacturing practice. 
2 4. The antigenic potential of soya protein is lower than that of milk protein, particularly lactosérum 
(whey) protein. That is why some thirty years ago soya proteins were recommended for children 
who were allergic to cows' milk protein. However, there are very well documented reports of 
severe gastro-intestinal reactions in the form of vomiting, diarrhoea, weight loss, villose atrophy 
and even characteristic allergy symptoms as a result of feeding with soya protein. Intolerance 
associated with milk and soya protein or intolerance caused by these proteins has also been 
reported. This multi-sensitization could be ascribed to the increase in the permeability of the 
intestine to foreign proteins induced by the intestinal lesions which the foreign proteins may cause. 
The idea was also put forward that these proteins - which were thought to be non-antigenic - could 
cause allergy-type reactions if they are ingested at a time when there are clinical signs of an 
intolerance to cows' milk. Less antigenic formulae (e.g. protein hydrolysates) should therefore be 
used in preference to soya-based protein for infants who are allergic or who show signs of 
intolerance to dietary protein
 24. 
The possibility of preventing the appearance of allergy symptoms in families at risk and in the 
population at large through the use of soya-based formulae has also been called into question. 
Even extremely well controlled studies have not revealed any difference in the development of an 
allergy that could be ascribed to the type of food administered to infants 46; other studies have, on 
the contrary, highlighted the protective effect of breast feeding and 'elementary' food compared 
with milk or soya-protein-based formulae
 24· 47. Under these circumstances, the 
Committee felt that soya-based products might possibly be regarded as substitutes 
for cows' milk in children suffering from an intolerance to these proteins, but that 
no reference should be made to the possible protective role of soya-based 
products as regards allergy. 
2 5. Lastly, the question of the minimum requirements for products combining milk protein and soya 
protein was discussed. The possibility that this type of formula might eventually be marketed in the 
Community cannot be ruled out. Taking all of the issues into account, the Committee 
held that all of the provisions proposed in § § 11, 12, 15, 16, 17, 18, 20, 21, 22, 
23, and 24 should apply equally to soya-protein-based products and to those 
combining milk protein and soya protein. The provisions of § 14 are, clearly, the 
only ones which cannot be applied to 'combined' products. Finally, it should be 
mentioned on the packaging of these products that in spite of partial replacement 
of milk by soya proteins, they do contain lactose and cows' milk protein. 
26. As mentioned above (see § 1), this opinion supplements the opinion expressed previously in 1983 
by the Committee on the minimum requirements for infant formulae and follow-up milks based on 
cows' milk proteins. The relevant annexes of the 1983 report have been modified in order to take 
into account the recommendations expressed here, and to make them applicable to preparations 
covered by both opinions. For the sake of clarity, all the annexes are included in the present 
document. ANNEXES Annex 1 
Infant Formulae -
Essential Composition of the Product Ready for Use 
when Reconstituted as Instructed by the Manufacturer 
1. Energy 
Minimum 
250 kJ/100 ml 
60 kcal/100 ml 
Maximum 
315 kJ/100 ml 
75 kcal/100 ml 
2. Proteins 
(Protein content = nitrogen content χ 6.38) for cows' milk proteins. 
(Protein content = nitrogen content χ 6.25) for soya protein isolates. 
2.1 Formulae manufactured from unmodified cows' milk proteins 
2.2 
2.3 
Minimum 
0.56 g/100 kJ 
(2.25 g/100 kcal) 
Maximum 
0.7 g/100 kJ 
(3 g/100 kcal) 
• The chemical index of die proteins present shall be equal to at least 80% of that of the reference 
protein (breast milk, as defined in Annex 7); nevertheless, for calculation purposes, the 
concentrations of methionine and cystine may be added together. 
• The 'chemical index' shall mean the lowest of the ratios between the quantity of each essential 
amino-acid of the test protein and the quantity of each corresponding amino-acid of the reference 
protein. 
Formulae manufactured from modified cows' milk proteins (alteration 
of the casein/whey protein ratio) 
Minimum 
0.45 g/100 kJ 
(1.8 g/100 kcal) 
Maximum 
0.7 g/100 kJ 
(3 g/100 kcal) 
• For an equal energy value, the formula must contain an available quantity of each essential and 
semi-essential amino-acid at least equal to that contained in the reference protein (breast milk, as 
defined in Annex 6). 
Formulae manufactured from soya protein isolates, alone or in a 
mixture with cows' milk proteins 
Minimum Maximum 
0.56 g/100 kJ 0.7 g/100 kJ 
(2.25 g/100 kcal) (3 g/100 kcal) 
• Only soya protein isolates must be used in manufacturing these formulae. 
• The chemical index shall be equal to at least 80% of that of the reference protein Øjreast milk, as 
defined in Annex 7). 
• For an equal energy value the formula must contain an available quantity of methionine at least 
equal to mat contained in the reference protein Abreast milk, as defined in Annex 6). 
• The L-carnitine content shall be equal to at least 1.8 pmoles/100 kJ (7.5 pmoles/lOO kcal). 
11 2.4 In all cases, the addition of amino-acids is permitted solely for the purpose of improving the 
nutritional value of the proteins, and only in the proportions necessary for that purpose. 
3. Lipids 
Minimum Maximum 
0.8g/100kJ 1.5g/100kJ 
(3.3 g/100 kcal) (6.5 g/100 kcal) 
3.1 The use of the following substances is prohibited 
• sesame oil; 
• cotton oil; 
• fats containing more than 8% trans- isomers of fatty acids. 
3.2 Laurie acid 
Minimum Maximum 
— 15% of the total fat content 
3.3 Myristic acid 
Minimum Maximum 
— 15 % of the total fat content 
3.4 Linoleic acid (in the form of glyc eride s = linoleates) 
Minimum Maximum 
70 mg/100 kJ 285 mg/100 kJ 
(300 mg/100 kcal) (1200 mg/100 kcal) 
4. Carbohydrates 
Minimum Maximum 
1.7 g/100 kJ 3.4 g/100 kJ 
(7g/100kcal) (14 g/100 kcal) 
4.1 Only the following carbohydrates may be used 
• lactose; 
• maltose; 
• sucrose; 
• malto-dextrins; 
• corn syrup solids; 
• pre-cooked starch (naturally free of gluten) 
• gelatinized starch (naturally free of gluten) 
4.2 Lactose 
Minimum Maximum 
0.85 g/100 kJ — 
(3.5 g/100 kcal) 
• This provision does not apply to formulae in which soya proteins represent more than 50% of the 
total protein content. 
12 4.3 Sucrose 
Minimum Maximum 
— 20% of the total 
carbohydrate content 
4.4 Pre-cooked starch andlor gelatinised starch 
Minimum Maximum 
— 2 g/100 ml, and 
30% of the total 
carbohydrate content 
5. Mineral substances 
5.1 Formulae manufactured from cows' milk proteins 
Sodium (mEq) 
Potassium (mEq) 
Chlorine (mEq) 
Calcium (mg) 
Phosphorus (mg) 
Magnesium (mg) 
Iron (mg)
a 
Zinc (mg) 
Copper (pg) 
Iodine (ug) 
Per 
Minimum 
0.25 
0.4 
0.35 
12 
6 
1.2 
0.12 
0.07 
4.8 
1.2 
100 kJ 
Maximum 
0.6 
0.9 
0.8 
— 
22 
3.6 
0.36 
— 
19 
— 
Per 
inimuiTi 
1  1.6 
1.4 
50 
25 
5 
0.5 
0.3 
20 
5 
100 kcal 
t Maximi 
2.6 
3.8 
3.5 
— 
90 
15 
1.5 
— 
80 
— 
• The calcium/phosphorus ratio shall not be less than 1.2 nor greater than 2.0. 
5.2 Formulae manufactured from soya protein isolates, alone or in a 
mixture with cows' milk proteins 
All requirements of paragraph 5.1 are applicable except those concerning iron and zinc, which are as 
follows: 
Per 100 kJ Per 100 kcal 
Minimum Maximum Minimum Maximum 
Iron (mg) 0.25 0.5 1 2 
Zinc (mg) 0.18 — 0.75 — 
a Limit applicable to formulae with added iron. 
13 Vitamins 
Vitamin A (pg RE)
b
 
Vitamin D (pg)
c
 
Thiamine (pg) 
Riboflavin (p-g) 
Nicotinamide (pgNE)
d
 
Pantothenic acid (pg) 
Vitamin Bö (pg) 
Biotin (pg) 
Folie acid (pg) 
Vitamin Β12 (pg) 
Vitamin C (mg) 
Vitamin E (mg a-TE)
e
 
Per 100 kJ 
Minimum Maximum 
14 43 
0.25 0.5 
10 — 
14 — 
60 — 
70 — 
9 — 
0.4 — 
1 — 
0.025 — 
1.9 — 
0.5/g 
of poly-
unsaturated 
fatty acids 
expressed as 
linoleic acid 
but in no case 
less than 0.1 mg 
per 100 available kJ 
Per 100 kcal 
Minimum Maximum 
60 
1 
40 
60 
250 
300 
35 
1.5 
4 
0.1 
8 
0.5/g 
of poly-
unsaturated 
fatty acids 
expressed as 
linoleic acid 
180 
2 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
but in no case 
less than 0.5 mg 
per 100 available kcal 
b RE = all-trans retinol equivalent. 
c In the form of cholecalciferol, of which 10 pg = 400 i.u. of vitamin D 
d NE = Niacin equivalent = mg nicotinic acid + mg tryptophan/60 
e a-TE = D-a-tocopherol equivalent 
- 14 Annex 2 
Follow-Up Milks -
Essential Composition of the Product Ready for Use 
when Reconstituted as Instructed by the Manufacturer 
1. Energy 
Minimum 
250 kJ/100ml 
(60 kcal/100 ml) 
Maximum 
335 kJ/100ml 
(80 kcal/100 ml) 
2. Proteins 
Q?rotein content = nitrogen content χ 6.38) for cows' milk proteins. 
0?rotein content = nitrogen content χ 6.25) for soya protein isolates. 
Minimum 
0.5 g/100 kJ 
(2.25 g/100 kcal) 
Maximum 
lg/100kJ 
(4.5 g/100 kcal) 
The chemical index of the proteins present shall be equal to at least 85% of that of the reference 
protein (casein, as defined in Annex 7). 
The 'chemical index' shall mean the lowest of the ratios between the quantity of each essential 
amino-acid of the test protein and the quantity of each corresponding amino-acid of the reference 
protein. 
For follow-up milks manufactured from soya proteins, alone or in a mixture with cows' milk 
proteins, only protein isolates from soya may be used and the L-carnitine content shall be at least 
equal to 1.8 pmoles/100 kJ (7.5 pmoles/100 kcal). 
Amino-acids may be added to follow-up milks for the purpose of improving the nutritional value 
of the proteins, in the proportions necessary for that purpose. 
3. Lipids 
Minimum 
0.8 g/100 kJ 
(3.3 g/100 kcal) 
Maximum 
1.5 g/100 kJ 
(6.5 g/100 kcal) 
3.1 The use of the following substances is prohibited: 
• sesame oil; 
• cotton oil; 
• fats containing more than 8% trans- isomers of fatty acids. 
3.2 Laurie acid 
Minimum  Maximum 
15% of the total fat content 
15 3.3 Myristic acid 
Minimum  Maximum 
15% of the total fat coment 
3.4 Linoleic acid (in the form of glycerides = linoleates) 
Minimum Maximum 
70 mg/100 kJ — 
(300 mg/100 kcal): 
this limit applies only 
to follow-up milks 
containing vegetable oils 
4. Carbohydrates 
Minimum 
1.7 g/100 kJ 
(7 g/100 kcal) 
Maximum 
3.4 g/100 kJ 
(14 g/100 kcal) 
4.1 The use of ingredients containing gluten is prohibited. 
4.2 Lactose 
Minimum 
0.45 g/100 kJ 
(1.8 g/100 kcal) 
Maximum 
This provision does not apply to follow-up milks in which soya protein isolates represent more 
than 50% of the total protein content. 
4.3 Sucrose, Fructose, Honey 
Minimum  Maximum 
separately or as a whole: 
20% of the total carbohydrate content. 
5. Mineral substances 
5.1 Iron 
Minimum 
0.25 mg/100 kJ 
(1 mg/100 kcal) 
5.2 Zinc 
Maximum 
0.5 mg/100 kJ 
(2 mg/100 kcal) 
5.2.1 Follow-up milks manufactured entirely from cows' milk 
Minimum Maximum 
0.12 mg/100 kJ — 
(0.5 mg/100 kcal) 
16 5.2.2 Follow-up milks manufactured from soya protein isolates, alone or mixed with cows' milk 
Minimum Maximum 
0.18 mg/100 kJ — 
(0.75 mg/100 kcal) 
5.3 Other mineral substances 
• Their concentrations should be at least the concentrations normally found in cows' milk, reduced, 
where appropriate, in the same ratio as the protein concentration of the follow-up milk to that of 
cows' milk. The typical composition of cows' milk is given, for guidance, in Annex 8. 
5.4 The calcium/phosphorus ratio shall not exceed 2.0. 
6. Vitamins 
Vitamin A 
Vitamin D 
Vitamin C 
Vitamin E 
(pg RE)
a
 
tø)
b 
(mg) 
(mg a-TE)
c
 
Per 100 kJ 
Minimum Maximum 
14 
0.25 
1.9 
0.5/g 
of poly-
unsaturated 
fatty acids 
expressed as 
linoleic acid 
43 
0.5 
— 
but in no case 
less than 0.1 mg 
per 100 available kJ 
Per 100 kcal 
Minimum Maximum 
60 180 
1 2 
8 — 
0.5/g 
of poly-
unsaturated 
fatty acids 
expressed as 
linoleic acid 
but in no case 
less than 0.5 mg 
per 100 available kcal 
a RE = all trans retinol equivalent. 
b In the form of cholecalciferol, of which 10 pg = 400 i.u. of vitamin D. 
c α-ΤΕ = D-a-tocopherol equivalent.. 
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Specific Compositional Criteria for Infant Formulae, 
Warranting a Corresponding Claim 
Composition 
criterion 
Protein 
Sodium 
Sucrose 
Lactose 
Lactose 
Iron 
Conditions 
warranting a claim 
The protein content is lower than 0.6 g/100 kJ 
(2.5 g/100 kcal) and 
the whey protein/casein ratio is not less than 1.0 
The sodium content is lower than 0.4 mEq/100 kJ 
(1.7mEq/100kcal) 
No sucrose is present 
Lactose is the only carbohydrate used 
No lactose is present 
Iron is added 
18-Annex 4 
Nutritional Substances 
1. Vitamins 
Vitamin 
Vitamin A 
Vitamin D 
Vitamin Bi 
Vitamin B2 
Nicotinamide 
Vitamin BÖ 
Folic acid 
Pantothenic acid 
Vitamin Bi 2 
Vitamin H 
Vitamin C 
Vitamin E 
Vitamin K 
Vitamin formulation 
Vitamin A acetate 
Vitamin A palmitate 
Beta-carotene Oleovitamin A) 
Vitamin D2 (ergocalciferol) 
Vitamin D3 (cholecalciferol) 
Vitamin D3 cholesterol 
Thiamine hydrochloride 
Thiamine mononitrate 
Riboflavin 
Riboflavin 5'-sodium phosphate 
Niacinamide 
Nicotinic acid (niacin) 
Pyridoxine hydrochloride 
Pyridoxal 5'-phosphate 
Folic acid 
D-calcium pantothenate 
D-sodium pantothenate 
D-panthenol 
Cyanocobalamin 
Hydroxycobalarnin 
D-biotin 
L-ascorbic acid 
Sodium L-ascorbate 
Calcium L-ascorbate 
L-ascorbyl 6-palmitate 
Potassium ascorbate 
D-a-tocopherol 
DL-a-tocopherol 
D-a-tocopherol acetate 
DL-a-tocopherol acetate 
Vitamin Κι 
19-Special vitamin formulations 
• For reasons of stability and handling, some vitamins have to be converted into suitable preparations, 
for example stabilized oily solutions, gelatine-coated products and fat-coated preparations. For this 
purpose, edible substances and additives recommended in the present document may be used. In 
addition, the following substances are permitted: 
Gelatine, gum arabic (acacia gum), silicon dioxide (as an anti-caking agent): maximum level 10 g/kg 
in the vitamin preparation. 
2. Mineral substances 
Mineral 
substances 
Calcium (Ca) 
Phosphorus (P) 
Permitted 
salts 
Calcium carbonate 
Calcium chloride 
Calcium citrate 
Calcium gluconate 
Calcium glycerophosphate 
Calcium lactate 
Calcium phosphate, monobasic 
Calcium phosphate, dibasic 
Calcium phosphate, tribasic 
Calcium hydroxide 
Calcium phosphate, monobasic 
Calcium phosphate, dibasic 
Calcium phosphate, tribasic 
Magnesium phosphate, dibasic 
Magnesium phosphate, tribasic 
Potassium phosphate, monobasic 
Potassium phosphate, dibasic 
Sodium phosphate, dibasic 
Magnesium (Mg)  Magnesium carbonate 
Magnesium chloride 
Magnesium oxide 
Magnesium phosphate, dibasic 
Magnesium phosphate, tribasic 
Magnesium sulphate 
Magnesium gluconate 
Iron (Fe)  Ferrous citrate 
Ferrous gluconate 
Ferrous lactate 
Ferrous sulphate 
Ferrous ammonium citrate 
Copper (Cu)  Cupric citrate 
Cupric gluconate 
Cupric sulphate 
Copper Lysine Complex 
Copper carbonate 
Iodine (J)  Potassium iodide 
Sodium iodide 
Potassium iodate 
20-Zinc (Zn)  Zinc acetate 
Zinc chloride 
Zinc lactate 
Zinc sulphate 
Zinc citrate 
Manganese (Mn) 
Sodium (Na) 
Potassium (K) 
Manganese carbonate 
Manganese chloride 
Manganese citrate 
Manganese sulphate 
Manganese gluconate 
Sodium bicarbonate 
Sodium chloride 
Sodium citrate 
Sodium gluconate 
Sodium carbonate 
Sodium lactate 
Sodium phosphate, monobasic 
Sodium phosphate, dibasic 
Sodium phosphate, tribasic 
Sodium hydroxide 
Potassium bicarbonate 
Potassium carbonate 
Potassium chloride 
Potassium citrate 
Potassium gluconate 
Potassium lactate 
Potassium phosphate, monobasic 
Potassium phosphate, dibasic 
Potassium phosphate, tribasic 
Potassium hydroxyde 
3. Amino-acids and other nitrogen compounds 
L- arginine and its hydrochloride 
L- cystine and its hydrochloride 
L- histidine and its hydrochloride 
L- isoleucine 
L- leucine 
L- lysine 
L- and DL-methionine 
L- phenylalanine 
L- threonine 
L- tryptophan 
L- tyrosine 
L- valine 
L- carnitine 
Taurine 
4. Others 
Choline (choline chloride) 
Inositol 
-21 Annex 5 
Technological Additives 
Thickening 
agents 
E 407 Carragccnan 
E 410 Gum carob 
E 412 Gum guar 
Maximum level in 100 ml of the product 
ready for use when reconstituted 
as instructed by the manufacturer 
0.03 g in follow-up milks 
0.1 g in follow-up milks 
0.1 g in follow-up milks 
Emulsifiers 
E 322 Lecithin 
E 471 Mono- and di-glyceridcs 
0.5 g in infant formulae and follow-up milks 
0.4 g in infant formulae and follow-up milks 
Antioxidants 
E 300 L-ascorbic acid 
E 301 Sodium L-ascorbate 
E 302 Calcium L-ascorbate 
E 304 Ascorbyl palmitate 
E 306 Tocopherol-rich extracts 
of natural origin 
E 307 α-tocophcrol 
E 308 γ-tocophcrol 
E 309 δ-tocopherol 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
1 mg in infant formulae and follow-up milks 
Acidified milks 
For the manufacture of acidified milks, the addition of citric acid, L(+)-lactic acid or the culture method, 
producing lactic acid in situ, can be used. 
-22-Annex 6 
The Essential and Semi-Essential 
Amino-Acids in Breast Milk 
For the purpose of this report, the essential and semi-essential amino-acids in breast milk, expressed in mg per 
100 kJ and 100 kcal, are the following: 
Arginine 
Cystine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Threonine 
Tryptophan 
Tyrosine 
Valine 
Per 100 kJ* 
16 
6 
11 
17 
37 
29 
7 
15 
19 
7 
14 
19 
Per 100 kcal 
69 
24 
45 
72 
156 
122 
29 
62 
80 
30 
59 
80 
* 1 kJ = 0.239 kcal. 
23-Annex 7 
Amino-acid Composition 
of Casein and Breast Milk Protein 
The amino-acid composition of casein and breast milk protein (g/100 g of protein): 
Arginine 
Cystine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Threonine 
Tryptophan 
Tyrosine 
Valine 
Casein 
3.7 
0.3 
2.9 
5.4 
9.5 
8.1 
2.8 
5.2 
4.7 
1.6 
5.8 
6.7 
Breast Milk* 
3.8 
1.3 
2.5 
4.0 
8.5 
6.7 
1.6 
3.4 
4.4 
1.7 
3.2 
4.5 
* Amino-acid content of foods and biological data on protein. FAO Nutritional Studies, No. 24, Rome 1970, 
items 375 and 383. 
24 Annex 8 
The Mineral Elements in Cows' Milk 
As a reference, the contents of mineral elements in cows' milk expressed per 100 g of solids-non-fat and per 
gram of proteins are the following: 
Sodium (mEq) 
Potassium (mEq) 
Chlorine (mEq) 
Calcium (mg) 
Phosphorus (mg) 
Magnesium (mg) 
Copper (pg) 
Iodine 
Per  100 g SNF
a 
24 
43 
30 
1350 
1070 
135 
225 
NS
b 
Per  g of proteins 
0.65 
1.1 
0.8 
35 
28 
3.5 
6 
NS 
a SNF: solids-non-fat. 
b NS: non specified, varies widely according to season and stock farming conditions. 
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